Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
Cypress Bioscience Announces Third Quarter 2009 Financial Results
Cypress Bioscience Announces Second Quarter 2009 Financial Results
StockPreacher.com Issues Trading Outlook for Orexigen Therapeutics Inc.
Cypress Bioscience, Inc. to Present at Jefferies 3rd Annual Healthcare Conference
Cypress Bioscience, Inc. Announces First Quarter 2009 Financial Results
Cypress Bioscience, Inc. CEO Jay Kranzler Named Ernst & Young Entrepreneur Of The Year(R) Finalist in San Diego
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
Cypress Bioscience, Inc. to Present at Citi's 4th Annual Biotech Day
Zacks Analyst Blog Highlights: Cypress Biosciences, Forest Labs, ArvinMeritor, Apogee Enterprises and The Macerich Company - Mar 18 2009 7:17AM
Cypress Bioscience, Inc. to Present at Cowen and Company 29th Annual Health Care Conference
Cypress Bioscience, Inc. Announces 2008 Financial Results
Cypress Bioscience, Inc. to Present at Barclays Capital Global Healthcare Conference
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM)
Cypress Bioscience, Inc. Acquires Personalized Medicine Technology Platform From Cellatope Corporation
Cypress Bioscience, Inc. to Present at Roth Capital Partners 21st Annual OC Growth Stock Conference
Zacks Analyst Blog Highlights: Allianz Aktiengesell, Advanced Micro Devices, Inc., Schlumberger Limited, Forest Labs and Cypress Biosciences.
Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia
Zacks Analyst Blog Highlights: Qualcomm, Inc., Nokia, Johnson & Johnson, Cypress Bioscience, Inc. And Forest Laboratories, Inc.
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
Cypress Bioscience, Inc. to Present at RBC Capital Markets Healthcare Conference
Cypress Bioscience, Inc. Announces Third Quarter 2008 Results
Cypress Bioscience, Inc. to Present at Oppenheimer 19th Annual Healthcare Conference
Cypress Bioscience Launches Two New Personalized Medicine Services for Rheumatologists
FDA Defers Final Action on milnacipran New Drug Application
Wall Street Media Presents Exclusive Videos from the JMP Healthcare Focus Conference - Oct 8 2008 3:21PM
Cypress Bioscience, Inc. to Present at Upcoming Investor and Industry Conferences
Cypress Bioscience, Inc. to Present at UBS Global Life Sciences Conference
Cypress Bioscience, Inc. to Participate in Citi's 3rd Annual Biotech Day
Cypress Bioscience, Inc. Announces Second Quarter 2008 Results
Cypress Bioscience, Inc. to Present at Oppenheimer Small & Mid Cap Clinical & Regulatory Conference
Cypress Bioscience, Inc. to Present at Jefferies 2nd Annual Healthcare Conference
Cypress Bioscience, Inc. to Present at Needham & Company Biotechnology and Medical Technology Conference
Cypress Bioscience, Inc. to Present at FBR Capital Markets Spring Investor Conference - May 26 2008 10:32PM
Cypress Bioscience, Inc. to Present at Citi's Health Care Conference - May 27 2008 12:56AM
Cypress Bioscience, Inc. Announces First Quarter 2008 Results - Jun 1 2008 5:15PM
Cypress Bioscience, Inc. to Present at The Neurotech Industry Investing & Partnering Conference - Jun 1 2008 5:14PM
Cypress Bioscience, Inc. to Present at Deutsche Bank Health Care Conference - Jun 1 2008 5:14PM
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia